Krystal Biotech, Inc. (KRYS)
250.08
-1.60
(-0.64%)
USD |
NASDAQ |
Mar 23, 16:00
250.15
+0.07
(+0.03%)
After-Hours: 20:00
Krystal Biotech Shareholders Equity (Quarterly) : 1.220B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 274.24M |
| Scholar Rock Holding Corp. | 245.49M |
| Alkermes Plc | 1.819B |
| Stoke Therapeutics, Inc. | 352.46M |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.334B |
| Total Liabilities (Quarterly) | 114.23M |
| Debt to Equity Ratio | 0.0077 |
| Current Ratio | 9.953 |
| Net Debt Paydown Yield | -0.01% |